Quarterly report pursuant to Section 13 or 15(d)

Statements of Stockholders' Equity (Deficit) (unaudited)

v3.19.3.a.u2
Statements of Stockholders' Equity (Deficit) (unaudited) - USD ($)
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Total
Balance at beginning at Sep. 30, 2018 $ 832,013 $ 36,640,009 $ (41,858,257) $ (4,386,235)
Balance at beginning (in shares) at Sep. 30, 2018 832,013,272      
Stock based compensation   393,000   393,000
Common stock and warrants issued for cash $ 19,325 946,925   966,250
Common stock and warrants issued for cash (in shares) 19,325,000      
Net Loss     (346,319) (346,319)
Balance at end at Dec. 31, 2018 $ 851,338 37,979,934 (42,204,576) (3,373,304)
Balance at end (in shares) at Dec. 31, 2018 851,338,272      
Balance at beginning at Sep. 30, 2019 $ 1,092,266 54,160,836 (55,582,010) $ (328,908)
Balance at beginning (in shares) at Sep. 30, 2019 1,092,266,844     1,092,266,844
Cumulative adjustment upon ASC 842 adoption     16,429 $ 16,429
Stock based compensation   367,841   367,841
Common stock issued for conversion of convertible note payable and accrued interest $ 17,920 530,471   548,391
Common stock issued for conversion of convertible note payable and accrued interest (in shares) 17,919,455      
Common stock registration costs   (15,398)   (15,398)
Stock Issued to extinguish liability $ 38,423 1,498,506   1,536,929
Stock Issued to extinguish liability (in shares) 38,423,221      
Net Loss     (153,143) (153,143)
Balance at end at Dec. 31, 2019 $ 1,148,609 $ 56,542,256 $ (55,718,724) $ 1,972,141
Balance at end (in shares) at Dec. 31, 2019 1,148,609,520     1,092,266,844